Immunotherapy combo aims to shrink colon tumors before surgery
Disease control
Not yet recruiting
This study tests whether two immunotherapy drugs, cemiplimab and fianlimab, can safely shrink colon tumors before surgery in people with stage II-III colon cancer that hasn't spread. Participants get two IV doses before surgery, then are followed for up to three years. The goal i…
Phase: PHASE2 • Sponsor: John Strickler, M.D. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC